Contents
Special Issue Topic

Theranostic Frontiers in Neuro-Oncology

Guest Editor

Prof. Chunsheng Kang E-Mail

Deputy Director of Tianjin Neurology Institute, Director of Neuro-tumor Laboratory of Tianjin Medical University General Hospital, Tianjin, China

Research Keywords: Nano-medicine; signaling pathways; exosome and endocytosis; gene editing; neuro-oncology

About the Special lssue

Among the tumors of the central nervous system, glioblastoma is currently the most challenging tumor for neurosurgeons. Benign tumors are also challenging diseases for surgical procedures because of deep location with brain. In recent years, with the development of genomics, proteomics and metabolomics, the understanding of neuro-oncology has been deepened, and new diagnostic markers, diagnostic techniques and treatment strategies have been developed in both clinical diagnosis and therapeutics. The special issue will focus on the application of new methods, viewpoints and technologies for the diagnosis and treatment of brain tumors including brain metastases. Novel research methods including immune markers and single-cell sequencing are also welcome. The topic will cover the scope of imaging, pathology, neurosurgery, neuro-oncology and basic research. Reviews, comments and research article within the scope are welcomed for submission.

Keywords: Neuro-oncology; brain metastasis; imaging; surgical technology; pathology; biomarker; single cell sequencing; immunology

Published Articles

Open Access Original Article
Imaging of supratentorial ependymomas with radio-pathological correlation
Arpita Sahu ... Epari Sridhar
Published: June 27, 2024 Explor Target Antitumor Ther. 2024;5:766–779
1415 17 0
Open Access Review
Research progress in molecular pathology markers in medulloblastoma
Zixuan Zhou ... Shangfeng Gao
Published: February 28, 2023 Explor Target Antitumor Ther. 2023;4:139–156
2185 32 2
Open Access Review
Liquid biopsy and glioblastoma
Robert H. Eibl, Markus Schneemann
Published: February 25, 2023 Explor Target Antitumor Ther. 2023;4:28–41
4293 82 15
Open Access Perspective
Encouraging probiotics for the prevention and treatment of immune-related adverse events in novel immunotherapies against malignant glioma
Sayuri Yoshikawa ... Satoru Matsuda
Published: December 27, 2022 Explor Target Antitumor Ther. 2022;3:817–827
4867 1744 8
Open Access Review
Perspectives of traditional Chinese medicine to patch up immune checkpoint blockers
Shiu Ying Tsao
Published: October 31, 2022 Explor Target Antitumor Ther. 2022;3:676–693
2628 26 1